300
Participants
Start Date
September 27, 2023
Primary Completion Date
August 19, 2024
Study Completion Date
January 27, 2025
Aceclidine+Brimonidine combination ophthalmic solution
Aceclidine+Brimonidine combination ophthalmic solution
Aceclidine ophthalmic solution
Aceclidine ophthalmic solution
Placebo (Vehicle) ophthalmic solution
Placebo (Vehicle) ophthalmic solution
Eye Hospital, Wenzhou Medical University, Wenzhou
Beijing Tongren Hospital, Capital Medical University, Beijing
Peking University First Hospital, Beijing
The Second Xiangya Hospital of Central South University, Changsha
Ineye Hospital of Chengdu University of TCM, Chengdu
Dalian N0.3 people's hospital, Dalian
Guang Zhou Aier eye Hospital, Guangzhou
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou
The Affiliated Hospital of Guizhou Medical University, Guiyang
Affiliated Eye Hospital, Shandong University of Traditional Chinese Medicine, Jinan
Shanghai Eye Disease Prevention and Treatment Center, Shanghai
Tongji Hospital Of Tongji University, Shanghai
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School Of Medicine, Shanghai
Shanxi Eye Hospital, Taiyuan
Tianjin Eye Hospital, Tianjin
Tianjin Medical University Eye Hospital, Tianjin
Wuhan Aier Eye Hospital, Wuhan
Xi'An People's Hospital, Xi'an
Henan Eye Hospital & Henan Institute, Zhengzhou
Lead Sponsor
Collaborators (1)
LENZ Therapeutics, Inc
OTHER
Corxel Pharmaceuticals
INDUSTRY